The chemicals termed as RNF10 activators predominantly interface with diverse cellular pathways and systems, suggesting an intricate and vast operational grid in which RNF10 may function. For instance, Forskolin's ability to augment cAMP levels presents a modulatory effect on numerous cellular processes, some of which could intersect with RNF10's ambit. Chemicals like MG132 and Epoxomicin inhibit the proteasome, thus impacting ubiquitin-proteasome pathways, an arena that can be linked with RNF10's ubiquitin ligase activities.
PI3K inhibitors like LY294002 and Wortmannin, along with the mTOR inhibitor Rapamycin, emphasize the interplay between the PI3K-AKT-mTOR axis and various proteins. This axis can converge with RNF10's operational sphere, influencing its activity. Furthermore, inhibitors such as U0126, PD98059, and SB203580 target kinases central to the MAPK pathways, underlining the interwoven nature of cellular signaling. By modulating these paths, they can impart an effect on RNF10-associated events. Ionomycin and Thapsigargin, by modulating calcium dynamics and inducing ER stress respectively, highlight the intricate cellular equilibrium where even minor alterations can reflect across multiple proteins, encompassing the realm of RNF10.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can influence a variety of cellular processes including those associated with RNF10. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can affect ubiquitin-proteasome processes, potentially linked with RNF10's function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Another proteasome inhibitor that can influence ubiquitin-proteasome systems related to RNF10. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. The PI3K pathway interacts with many proteins; it can indirectly influence RNF10 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor which might influence processes associated with RNF10. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; as mTOR signaling affects numerous cellular processes, it may affect RNF10-associated functions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK; this modulation might affect pathways that interlink with RNF10 functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially modulating cellular activities where RNF10 is involved. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
γ-secretase inhibitor which impacts Notch signaling, potentially influencing RNF10 functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular calcium levels, potentially impacting RNF10-associated processes. | ||||||